Occudo Quantitative Strategies LP Eloxx Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.4 - $0.72 $11,796 - $21,234	-29,492 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.62 - $1.61 $7,533 - $19,561	-12,150 Reduced 29.18%	29,492 $21,000
Q3 2021 Nov 15, 2021	SELL	$1.22 - $2.0 $738 - $1,210	-605 Reduced 1.43%	41,642 $68,000
Q2 2021 Aug 16, 2021	BUY	$1.35 - $3.36 $57,033 - $141,949	42,247 New	42,247 $84,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.